Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2024-04-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
监事会决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of the company regarding various reports and proposals related to the 2023 annual report, financial statements, internal control evaluation, audit firm appointment, profit distribution plan, asset impairment, and the 2024 first quarter report. It includes voting results and states that these items will be submitted to the 2023 annual shareholders meeting for approval. The document does not contain the full annual report or financial statements but rather the Supervisory Board's review and approval of these documents and proposals. It is a formal announcement of board/management decisions and meeting resolutions, not the actual annual report or financial report itself. Therefore, it fits best under Board/Management Information (MANG). The document length is short (2045 characters), and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2024-04-24 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policy by the company, detailing the reasons, the new policy adoption date, and the impact of the change. It includes approvals from the audit committee, board of directors, supervisory board, and independent directors. The document is relatively short (1743 characters) and does not contain actual financial statements or detailed financial data. It is a formal announcement of a policy change rather than a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2024-04-24 Chinese
独立董事年度述职报告
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2023, detailing the director's duties, attendance, opinions, and activities related to corporate governance and oversight. It includes information about board meetings, audit committee activities, and supervisory roles but does not contain financial statements or detailed financial data. It is a report on management and governance activities rather than a financial report or announcement. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements related to board or senior management activities and reports.
2024-04-24 Chinese
会计师事务所履职情况评估报告及审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm and the audit committee's supervision of the accounting firm. It discusses the appointment, qualifications, and performance of the auditor for the 2023 fiscal year, including audit plans, audit scope, and supervisory activities by the audit committee. It does not contain the full annual report or the actual audit report but rather an assessment and oversight report related to the audit process. The document length is 2260 characters, which is relatively short and focused on audit oversight rather than financial statements or full audit results. Therefore, it fits best as an Audit Report / Information (AR) type, which includes standalone audit reports and evaluations of audit firms' performance, excluding full annual reports. FY 2023
2024-04-24 Chinese
2023年度独立董事述职报告（张大可）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2023 from a listed company. It details the director's duties, attendance, opinions, supervision activities, communication with auditors, and overall evaluation of the company's governance and financial reporting. It references the review and approval of the 2023 third quarter report but does not itself contain financial statements or detailed financial data. The document is a narrative report on the director's activities and governance role rather than a financial report or announcement. It is not a full annual report, audit report, or interim report. It is also not a regulatory filing or announcement of voting results. The content fits best with Board/Management Information (MANG), as it relates to the independent director's role and activities within the board and management structure.
2024-04-24 Chinese
第十届董事会独立董事专门会议2024年第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of a meeting of the independent directors of the company's board, specifically the 10th Board's first meeting in 2024. It includes resolutions passed on various governance and financial matters such as the internal control evaluation report, appointment of the audit firm, related party transactions, profit distribution plan, asset impairment provisions, accounting policy changes, and guarantees. The content focuses on board-level decisions and approvals rather than presenting full financial statements or comprehensive annual reports. The document is not a full annual report (10-K), audit report (AR), or interim report (IR), but rather a formal board/management information announcement about governance and management decisions. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (2762 characters) and detailed meeting content support this classification with high confidence.
2024-04-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.